Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site.

2 leading ASX growth shares to buy in November

This could be a great time to invest in ASX growth shares during November whilst markets are uncertain and there's a lot of volatility around.

This could be a great time to invest in ASX growth shares during November whilst markets are uncertain and there’s a lot of volatility around.

A fall of a share price doesn’t mean it’s not a good investment. In-fact, a cheaper price can be a good thing for a lot of companies because it simply means that investors can buy at a cheaper price.

Taking that into account, these are two of my preferred ASX growth share picks at the moment.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara Health Technologies Ltd (ASX: VHT) is an ASX healthcare share that offers software relating to breast screening for cancer. It also has software to help healthcare professionals to do their jobs (efficiently) and also analyse the images, which can help decide what patients should do next.

Volpara share price

One of the best things about Volpara is that it has a gross profit margin of more than 90%. That means that when it receives $100 of revenue, more than $90 of that turns into gross profit. This gross profit can then be used to invest in software development, marketing and other growth areas. As the business grows its costs should reduce less and it can continue to grow its other profit margins such as EBIT (EBIT explained), net profit after tax (NPAT) and cash flow.

In the quarter for the three months to 30 September 2023, it delivered the fourth consecutive positive net operating cash flow quarter of NZ$1.2 million, a full year and a half ahead of guidance. This rapid improvement bodes well for the future.

In the September quarter, it grew cash receipts by 32% to NZ$11.5 million.

Revenue can grow further from new contracts being won in the current countries, geographic expansion, selling more software to existing clients and the ASX growth share could expand in other areas, such as lung cancer screening.

VanEck Morningstar International Wide Moat ETF (ASX: GOAT)

This exchange-traded fund (ETF) is quite similar to the Vaneck Morningstar Wide Moat ETF (ASX: MOAT), except it’s the global version.

The VanEck Morningstar International Wide Moat ETF (ASX: GOAT) portfolio is decided by analysts that are looking for companies that have a strong economic moat, or competitive advantages. That can be in many different forms such as brand power, patents, network effects, cost advantages and so on. These kinds of businesses can produce stronger returns over time. The GOAT ETF only considers businesses where the economic moat is likely to endure for many years.

Not only that, but the analysts only decide to invest in these businesses with strong competitive advantages if the company is priced materially cheaper than what analysts currently think it’s worth.

Some businesses in the portfolio include Gilead SciencesTyler TechnologiesUS BancorpAlphabet and Nike.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz owns shares of VanEck Morningstar International Wide Moat ETF.
Skip to content